Nordic Nanovector - Financial Calendar

Wednesday, October 17, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

OSLO, Norway, Oct.17, 2018 /PRNewswire/ --

FINANCIAL YEAR 2018

Quarterly Report - Q3   06.11.2018 (changed from 21.11.2018) Quarterly

Report - Q4   27.02.2019

FINANCIAL YEAR 2019

Annual General meeting 25.04.2019 Quarterly Report - Q1     23.05.2019 Half-yearly Report          22.08.2019 Quarterly

Report - Q3     21.11.2019

The dates are subject to change. The time and location of the presentations will be announced in due time.

This information is published pursuant to the requirements set out in the Continuing obligations.

For further information, please contact: IR enquiries Malene BrondbergVP Investor Relations and Corporate Communications Cell: +44-7561-431-762 Email: ir@nordicnanovector.com International Media Enquiries Mark Swallow/David Dible (Citigate Dewe Rogerson) Tel: +44-207-638-9571 Email: nordicnanovector@citigatedewerogerson.com

About Nordic Nanovector Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting antibody-radionuclide-conjugate designed to advance the treatment of non-Hodgkin's lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets. Further information can be found at www.nordicnanovector.com

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/nordic-nanovector/r/nordic-nanovector---financial-calendar,c2646221

Cision View original content:http://www.prnewswire.com/news-releases/nordic-nanovector--financial-calendar-300732564.html

SOURCE Nordic Nanovector



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store